Microencapsulated insulin like growth factor 1 improves cardiac function after experimental infarction in absence of angiogenesis
Por:
Diaz, CB, Blanco-Blazquez, V, Crisostomo, V, Palacios, I, Galvez-Monton, C, Maestre, J, Mangas-Ballester, MT, Steendam, R, Hiemstra, C, Franssen, O, Bayes-Genis, A and Sanchez-Margallo, FM
Publicada:
1 ago 2017
Categoría:
Cardiology and cardiovascular medicine
Resumen:
Filiaciones:
Diaz, CB:
Jesus Uson Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain
Blanco-Blazquez, V:
Jesus Uson Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain
Crisostomo, V:
Jesus Uson Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain
Palacios, I:
Coretherapix Tigenix Grp, Madrid, Spain
:
IGTP, ICREC Res Programme Hlth Sci Res, Badalona, Barcelona, Spain
Maestre, J:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
Mangas-Ballester, MT:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
Steendam, R:
Innocore Pharmaceut BV, Groningen, Netherlands
Hiemstra, C:
Innocore Pharmaceut BV, Groningen, Netherlands
Franssen, O:
Nanomi BV, Oldenzaal, Netherlands
:
IGTP, ICREC Res Programme Hlth Sci Res, Badalona, Barcelona, Spain
Sanchez-Margallo, FM:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
|